Sg Americas Securities, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$36.99 - $50.09 $1.3 Million - $1.76 Million	35,234 New	35,234 $1.71 Million
Q4 2023 Jan 12, 2024	SELL	$44.49 - $62.93 $1.87 Million - $2.64 Million	-42,008 Reduced 82.81%	8,719 $539,000
Q3 2023 Oct 13, 2023	BUY	$45.51 - $65.0 $2.31 Million - $3.3 Million	50,727 New	50,727 $2.33 Million
Q1 2023 Apr 28, 2023	BUY	$27.99 - $37.92 $175,833 - $238,213	6,282 Added 59.33%	16,870 $633,000
Q4 2022 Feb 02, 2023	BUY	$27.93 - $31.27 $171,881 - $192,435	6,154 Added 138.79%	10,588 $297,000
Q3 2022 Oct 31, 2022	SELL	$27.56 - $37.75 $191,486 - $262,287	-6,948 Reduced 61.04%	4,434 $125,000
Q2 2022 Jul 29, 2022	SELL	$29.79 - $42.29 $566 - $803	-19 Reduced 0.17%	11,382 $396,000
Q1 2022 Apr 29, 2022	SELL	$22.96 - $36.45 $563,576 - $894,701	-24,546 Reduced 68.28%	11,401 $409,000
Q4 2021 Feb 07, 2022	SELL	$18.14 - $23.29 $791,919 - $1.02 Million	-43,656 Reduced 54.84%	35,947 $837,000
Q3 2021 Nov 01, 2021	BUY	$17.83 - $21.49 $1.42 Million - $1.71 Million	79,603 New	79,603 $1.51 Million
Q2 2021 Aug 12, 2021	SELL	$17.11 - $20.92 $93,882 - $114,788	-5,487 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$17.21 - $20.65 $94,431 - $113,306	5,487 New	5,487 $101,000
Q4 2020 Feb 04, 2021	SELL	$17.76 - $21.24 $1.49 Million - $1.78 Million	-83,818 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$17.99 - $22.22 $1.51 Million - $1.86 Million	83,818 New	83,818 $1.57 Million
Q2 2020 Jul 20, 2020	SELL	$14.25 - $22.46 $194,370 - $306,354	-13,640 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$12.66 - $20.08 $83,707 - $132,768	6,612 Added 94.08%	13,640 $202,000
Q4 2019 Jan 28, 2020	BUY	$17.07 - $20.64 $119,967 - $145,057	7,028 New	7,028 $136,000
Q2 2019 Jul 29, 2019	SELL	$18.92 - $22.96 $358,212 - $434,701	-18,933 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$19.46 - $25.28 $210,576 - $273,554	10,821 Added 133.39%	18,933 $387,000
Q4 2018 Feb 01, 2019	BUY	$17.72 - $22.51 $143,744 - $182,601	8,112 New	8,112 $161,000
Q3 2018 Nov 06, 2018	SELL	$15.39 - $19.38 $162,272 - $204,342	-10,544 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$14.63 - $19.6 $154,258 - $206,662	10,544 New	10,544 $161,000
Q4 2017 Jan 24, 2018	SELL	$17.76 - $19.75 $290,997 - $323,603	-16,385 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$14.73 - $17.99 $241,351 - $294,766	16,385	16,385 $293,000

Others Institutions Holding AMPH

# of Institutions

280

Shares Held

36.7M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account